CMS LEAD Model: Frequently Asked Questions

Answers to common questions about the CMS Long-term Enhanced ACO Design (LEAD) Model, the 10-year Medicare program launching January 1, 2027.

What is the CMS LEAD Model?

The CMS Long-term Enhanced ACO Design (LEAD) Model is a 10-year voluntary Medicare program launching on January 1, 2027, designed to expand and strengthen Accountable Care Organizations (ACOs). It rewards providers for delivering coordinated, preventive care that improves patient outcomes and reduces unnecessary healthcare costs. 

LEAD builds on lessons from the ACO REACH model—which ends in 2026—and introduces improved benchmarking, flexible payment structures, and stronger support for providers serving high-needs and dually eligible beneficiaries. It is administered by the CMS Innovation Center (CMMI).

When does the LEAD Model start and how long does it run?

The LEAD Model runs from January 1, 2027, through December 31, 2036—a 10-year performance period, making it the longest-running ACO model the CMS Innovation Center has ever launched. 

What are the core goals of the LEAD model?

LEAD is designed to achieve four primary objectives:

  1. Attract providers who have historically had limited or no ACO participation, including higher-spending practices
  2. Encourage evidence-based preventive care delivery
  1. Empower beneficiaries to take a more active role in their own care
  2. Improve care coordination and reduce costs for high-needs and dually eligible beneficiaries

What payment options are available under LEAD?

LEAD offers two prospective, per-beneficiary per-month (PBPM) capitated payment structures designed to move practices away from fee-for-service (FFS) toward value-based payment:

  • Primary Care Capitation (PCC): A monthly capitated payment covering primary care services, available under both the Professional and Global risk options. PCC consists of a Base Amount (based on historical primary care spending) and an Enhanced Amount (upfront infrastructure investment equal to the greater of 2% of the benchmark or the difference between 7% of the benchmark and the Base PCC).²
  • Total Care Capitation (TCC): A monthly capitated payment covering all Medicare services for aligned beneficiaries. TCC is available exclusively under the Global Risk Option. Participant TINs accepting TCC must accept a 100% fee reduction.

Both payment structures provide upfront cash flow to support investments in staffing, technology, telehealth, and chronic care management programs. 

What are the Professional and Global Risk Options?

LEAD offers two distinct risk-sharing tracks: 

  • Professional Risk Option: ACOs share up to 50% of savings or losses with CMS. No discount rate is applied. ACOs must remain in this option for at least four performance years before transitioning to Global Risk. This track suits practices newer to value-based care or those building ACO infrastructure.⁶
  • Global Risk Option: ACOs assume up to 100% of savings or losses. Only Global Risk ACOs are eligible for the positive regional efficiency adjustment, TCC payments, and participation in CARA. This track suits experienced ACOs ready for full accountability and maximum upside.

Vytalize models both options against each practice’s patient population, cost profile, and operational readiness to identify the best fit. 

Can a practice participate in both LEAD and MSSP at the same time?

No. LEAD and the Medicare Shared Savings Program (MSSP) are mutually exclusive. An ACO and its Participant TINs cannot simultaneously participate in LEAD and MSSP or the ACO Primary Care FLEX Model. 

Vytalize models both pathways—including MSSP BASIC, MSSP Enhanced, LEAD Professional, and LEAD Global—against each practice’s patient mix, prior savings history, and cost profile to identify the program and risk level most likely to generate savings in 2027.

How does benchmarking work under LEAD, and how is it different from ACO REACH?

LEAD introduces several significant benchmarking improvements over ACO REACH and MSSP: 

  • No rebasing: LEAD maintains consistent benchmark base years across all 10 performance years, eliminating the “ratchet effect” that historically penalized ACOs for successfully lowering costs.
  • No benchmark penalty for higher-spending ACOs: Under ACO REACH, ACOs whose patients spent above the regional average faced a downward benchmark adjustment. Under LEAD, this penalty is removed.
  • Accountable Care Prospective Trend (ACPT): LEAD uses a trending methodology that allows benchmarks to grow faster than actual realized spending when ACOs collectively lower costs, preserving long-term savings incentives.
  • Convergence over time: Over the 10-year period, benchmarks for both higher-spending and lower-spending ACOs gradually converge away from individual historical spending, rewarding improvement rather than baseline efficiency alone.
  • AI-based risk adjustment by 2029: CMS has announced a transition to AI-driven risk adjustment methodology beginning in 2029.

What Is the Administrative Add-On, and who qualifies?

The Administrative Add-On is a monthly capitated payment equal to 1.5% of an ACO’s total benchmark.¹ It is available to higher-spending ACOs—those with per-beneficiary spending above the regional average—to support investment in care coordination infrastructure and primary care capacity. 

Critically, the Administrative Add-On is not counted as a performance year expenditure and is not subject to repayment, making it a genuine structural advantage for practices that have historically faced unfavorable benchmark math in prior models. 

How does LEAD support practices serving high-needs and complex patients?

LEAD was specifically designed to improve the financial equation for practices caring for Medicare’s most complex patients. Key structural advantages include: 

  • Removal of the negative benchmark adjustment: Practices with above-regional-average spending no longer receive a downward benchmark penalty, removing a major disincentive that existed under ACO REACH. 
  • Concurrent risk adjustment for high-needs beneficiaries: Rather than setting risk scores based on prior-year diagnoses, LEAD applies the CMMI HCC Concurrent Risk Adjustment Model V2, which uses current-year diagnoses to capture rapidly escalating costs—such as acute crises, rapid decline, or end-of-life care—in real time.⁵
  • Lower alignment minimums: ACOs with at least 40% high-needs aligned beneficiaries qualify for a minimum alignment threshold of 800 beneficiaries in PY 1 (scaling to 1,600 by PY 5), compared to the standard minimum of 5,000.³ ⁴
  • 1.5% Administrative Add-On for higher-spending ACOs (see above). 
  • Expanded alignment pathways and benefit waivers tailored to high-needs and dually eligible populations. 

What is the CARA initiative?

CMS-Administered Risk Arrangements (CARA) is a voluntary specialist engagement initiative available exclusively to LEAD ACOs in the Global Risk Option. It enables ACOs to establish episode-based risk arrangements (EBRAs) with specialty care Preferred Providers using Episode-Based Cost Measures (EBCMs). 

CARA offers two configuration options: 

  • Default Approach: Uses standardized EBCM methodology with minor modifications
  • Max Flex Option: Allows ACOs to customize episode parameters, including trigger codes, episode length, and exclusions

CARA also includes the RISE to Age in Place episode—a specialized falls prevention program that deploys home-based interventions by occupational therapists and registered nurses. Episode activation begins on January 1, 2028, following a baseline data and contracting phase in 2027. 

How does Vytalize help practices navigate LEAD?

Vytalize models both MSSP and LEAD against each practice’s patient population, cost profile, and prior savings history—then places groups in the program and risk option that best fits. Whether a practice is new to value-based care and best positioned for MSSP BASIC or LEAD Professional, or an experienced ACO ready for LEAD Global with full capitation, Vytalize meets practices where they are. 

Vytalize’s support system includes seamless EHR integration, evidence-based clinical recommendations at the point of care, and an innovative financial model that rewards high-quality care. 

I need more information about the LEAD ACO model.

Vytalize Health has published a series of resources to help providers, partners, and their teams stay informed on the LEAD Model:

You can also visit the official CMS LEAD Model page for regulatory updates and application materials.

If you’d like to learn more about Vytalize’s 360-degree approach to work within your existing practice workflows while keeping patients at the center of care, read more here.

For Patients

My doctor joined LEAD. Does that affect my Medicare coverage or benefits?

No. If your doctor or practice joins the LEAD Model, your Medicare coverage and benefits remain completely unchanged.  

Can I still choose my own doctor if the practice joins LEAD?

Yes, absolutely. You retain full freedom to see any Medicare-enrolled physician, specialist, hospital, or supplier of your choice, at any time, regardless of whether they participate in the LEAD ACO. 

Your provider’s participation in LEAD is about how CMS pays for and coordinates your care behind the scenes. It does not change your rights as a Medicare beneficiary. 

If you’d like to learn more about how Vytalize helps your doctor provide better care, read more here.

[1] Centers for Medicare & Medicaid Services (CMMI), “Long-term Enhanced Accountable Care Organization Design (LEAD) Model: Request for Applications,” (Mar. 31, 2026), https://www.cms.gov/priorities/innovation/files/lead-rfa.pdf

[2] Centers for Medicare & Medicaid Services (CMMI), “LEAD Model RFA Webinar: Request for Applications Slides,” (Apr. 9, 2026), https://www.cms.gov/priorities/innovation/files/lead-model-rfa-slides.pdf

[3] Centers for Medicare & Medicaid Services (CMMI), “Long-term Enhanced ACO Design (LEAD) Model Performance Year 2027 Alignment Financial Methodology,” (July 14, 2026), https://www.cms.gov/priorities/innovation/files/lead-alignment-finance-paper.pdf

[4] Centers for Medicare & Medicaid Services (CMMI), “CMS LEAD Model Frequently Asked Questions,” (Apr. 18, 2026), https://www.cms.gov/priorities/innovation/lead-model-frequently-asked-questions

[5] Centers for Medicare & Medicaid Services (CMMI), “CMS LEAD Model: Technical FAQs,” (Apr. 18, 2026), https://www.cms.gov/priorities/innovation/files/lead-tech-faqs.pdf

[6] Centers for Medicare & Medicaid Services (CMMI), “LEAD Model Overview Webinar Slides,” (Jan. 29, 2026), https://www.cms.gov/priorities/innovation/files/lead-model-overview-slides.pdf